Skip to main content
Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
1.630
+0.010 (0.62%)
At close: Nov 13, 2026, 4:00 PM EST
1.590
-0.040 (-2.45%)
After-hours: Nov 13, 2026, 7:30 PM EST

Alaunos Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
00.010.010.012.920.4
Revenue Growth
-50.00%-50.00%100.00%-99.83%634.17%-
Gross Profit
-1.64-1.36-0.35-16.27-19.6-46.88
Operating Income
-4.06-4.23-4.81-28.49-32.74-73.15
Net Income
-4.12-4.28-4.68-35.14-37.73-78.75
Earnings Per Share
-1.77-2.20-2.92-21.97-26.10-55.10
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.121.391.096.0639.0676.05
Total Debt
----19.5129.37
Net Cash (Debt)
0.121.391.096.0619.5546.69
Net Cash Growth
-95.69%26.95%-82.00%-68.99%-58.13%-57.65%
Net Cash Per Share
0.050.710.683.7913.5032.66

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.73-2.87-4.97-30.14-29.23-61.47
Capital Expenditures
-0.1-0.1--0.2-0.22-3.32
Free Cash Flow
-2.83-2.97-4.97-30.34-29.45-64.79
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-135233.33%-84500.00%-48120.00%-569860.00%-1120.40%-18379.90%
Pretax Margin
-133666.67%-83520.00%-46790.00%-702800.00%-1291.24%-19786.68%
Profit Margin
-137200.00%-85640.00%-46790.00%-702800.00%-1291.24%-19786.68%
FCF Margin
-94166.67%-59340.00%-49710.00%-606780.00%-1007.80%-16279.15%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1380.331441.76305.043396.2853.20587.82